Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine for residual dizziness after Epley maneuver in posterior canal BPPV
TCTR20260304003Phase 4Completed
- Sponsor
- Thammasat University
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of betahistine in benign paroxysmal positional vertigo (BPPV), Residual Dizziness (RD), sponsored by Thammasat University. Started Jun 2023; status: completed.
02
Drugs
betahistine
03
Conditions
benign paroxysmal positional vertigo (BPPV)Residual Dizziness (RD)
Beyond the preview
Go deeper on TCTR20260304003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260304003.